Andrew Blight, Chief Scientifc Officer at ACORDA THERAPEUTICS INC (ACOR), sold 32,500 shares at $31.25 ($1.0M) on 2015-10-19, disclosed to the SEC on 2015-10-21.
Scheduled sale ($1.0M) by Chief Scientifc Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.82 | 28,800 | $888K | 88.5% |
| 2 | $31.25 | 3,700 | $116K | 11.5% |
| Total | $30.87 avg | 32,500 | $1.0M | 100% |
| Filing → |
| ACOR | SELL | 2015-11-23 | $19K | — | Filing → |
| ACOR | SELL | 2015-09-23 | $410K | — | Filing → |
| ACOR | SELL | 2014-10-22 | $1.7M | — | Filing → |